Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.21%597.93B | -14.02%2.41T | -8.37%591.53B | -16.77%627.5B | -20.72%596.7B | -8.76%599.2B | 35.40%2.81T | 9.29%645.59B | 39.00%753.9B | 48.42%752.63B |
Cost of revenue | -0.74%355.34B | -5.71%1.5T | -1.66%394.94B | -7.18%397.41B | -13.55%353.37B | 0.51%358B | 32.19%1.59T | 18.24%401.62B | 37.20%428.13B | 40.80%408.78B |
Gross profit | 0.58%242.59B | -24.95%911.21B | -19.42%196.6B | -29.37%230.09B | -29.24%243.33B | -19.74%241.2B | 39.87%1.21T | -2.83%243.97B | 41.45%325.77B | 58.63%343.85B |
Operating expense | 2.36%51.57B | -2.66%210.17B | 2.02%55.09B | -2.42%52.48B | -8.75%52.23B | -1.02%50.38B | 12.64%215.91B | -1.59%53.99B | 10.67%53.78B | 21.30%57.24B |
Operating profit | 0.11%191.02B | -29.77%701.04B | -25.51%141.51B | -34.70%177.61B | -33.33%191.1B | -23.56%190.82B | 47.59%998.2B | -3.18%189.97B | 49.68%271.99B | 69.01%286.62B |
Net non-operating interest income (expenses) | 79.05%21.28B | 340.56%66.46B | 132.91%21.21B | 369.98%16.88B | 757.10%16.48B | 2,467.17%11.89B | 982.91%15.09B | 2,294.70%9.11B | 3.59B | 1.92B |
Non-operating interest income | 69.27%21.28B | 310.01%67.96B | 127.12%21.6B | 284.49%17.99B | 852.08%15.8B | 1,629.44%12.57B | 597.60%16.58B | 1,574.12%9.51B | --4.68B | --1.66B |
Non-operating interest expense | ---- | 0.74%1.5B | -4.24%384M | ---- | ---- | 160.23%687M | 51.58%1.49B | --401M | ---- | ---- |
Net investment income | -43.31%6.73B | 527.17%13.65B | -82.96%1.22B | 15.86%11.87B | -122.40%-3.2B | 1,137.85%7.13B | ||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -86.65%950M | 19.18B | 5.23B | 1.6B | 5.24B | 7.11B | 0 | 0 | 0 | 0 |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -163.93%-12.96B | 237.08%3.71B | -2,231.05%-16.67B | 183.85%836M | -69.57%-836M | -341.94%-4.91B | -1,740.14%-2.71B | -346.88%-715M | -274.81%-997M | |
Less:Restructuring and mergern&acquisition | ---- | --15.16B | --45M | --15.11B | ---- | ---- | --0 | --0 | ---- | ---- |
Less:Other special charges | ---- | -144.77%-2.2B | -238.74%-3.75B | ---- | ---- | 69.57%836M | 341.94%4.91B | 1,740.14%2.71B | 346.88%715M | 274.81%997M |
Other non-operating income (expenses) | -77.01%776M | -44.70%8.31B | -249.45%-4.2B | 8.87%8.38B | -55.87%760M | 20.62%3.38B | 902.88%15.03B | 180.72%2.81B | 287.78%7.7B | -38.37%1.72B |
Income before tax | -1.55%220.76B | -22.01%795.67B | -7.60%181.1B | -34.12%174.71B | -27.25%215.63B | -14.62%224.23B | 46.55%1.02T | -4.78%195.99B | 41.98%265.19B | 71.63%296.39B |
Income tax | 7.63%66.11B | -10.16%230.51B | 6.43%56.94B | -12.00%55.91B | -22.79%56.25B | -7.93%61.43B | 49.96%256.59B | 7.63%53.5B | 35.99%63.53B | 70.68%72.85B |
Net income | -5.01%154.65B | -25.99%565.16B | -12.86%124.17B | -41.09%118.81B | -28.70%159.38B | -16.90%162.8B | 45.44%763.62B | -8.73%142.5B | 43.98%201.66B | 71.94%223.55B |
Net income continuous operations | -5.01%154.65B | -25.99%565.16B | -12.86%124.17B | -41.09%118.81B | -28.70%159.38B | -16.90%162.8B | 45.44%763.62B | -8.73%142.5B | 43.97%201.66B | 71.94%223.55B |
Noncontrolling interests | 15.88%10.63B | -18.71%45.02B | -17.40%10.56B | -11.31%13.72B | -24.57%11.58B | -22.22%9.17B | 122.29%55.38B | 39.71%12.78B | 97.38%15.47B | 217.46%15.35B |
Net income attributable to the company | -6.26%144.02B | -26.56%520.14B | -12.42%113.61B | -43.56%105.09B | -29.01%147.81B | -16.56%153.63B | 41.61%708.24B | -11.74%129.72B | 40.81%186.2B | 66.32%208.2B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -6.26%144.02B | -26.56%520.14B | -12.42%113.61B | -43.56%105.09B | -29.01%147.81B | -16.56%153.63B | 41.61%708.24B | -11.74%129.72B | 40.81%186.2B | 66.32%208.2B |
Gross dividend payment | ||||||||||
Basic earnings per share | -5.15%72.21 | -25.42%259.41 | -11.73%56.97 | -42.68%52.79 | -28.20%73.52 | -14.71%76.13 | 44.48%347.84 | -8.79%64.54 | 44.66%92.1 | 69.90%102.389 |
Diluted earnings per share | -5.17%72.13 | -25.45%259.13 | -11.74%56.9 | -42.74%52.71 | -27.90%73.46 | -14.73%76.06 | 44.51%347.61 | -8.83%64.47 | 44.75%92.06 | 69.20%101.88 |
Dividend per share | 0 | 0.00%100 | -9.09%50 | 0 | 11.11%50 | 0 | 25.00%100 | 10.00%55 | 0 | 50.00%45 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |